Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a 5.8% beneficial ownership stake in OCULAR THERAPEUTIX, INC.

BlackRock, Inc. has reported a 5.5% beneficial ownership stake in Orange County Bancorp, Inc. /DE/ as of September 30, 2025.

BlackRock, Inc. has reported an 8.3% beneficial ownership stake in Plug Power Inc., holding 98,183,530 shares of common stock as of September 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.8% beneficial ownership stake in Protagonist Therapeutics, Inc. as of September 30, 2025.

BlackRock, Inc. has reported an aggregate beneficial ownership of 10.6% of Qorvo, Inc.'s common stock, totaling 9,814,278 shares.

BlackRock, Inc. has disclosed a 5.4% beneficial ownership stake in Quantum Computing Inc., holding over 10 million shares of common stock.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.3% beneficial ownership of Ramaco Resources, Inc.'s Class A Stock as of September 30, 2025.

BlackRock, Inc. has reported beneficial ownership of 5.01% of Reddit Inc.'s Class A Stock, totaling 6,743,745 shares, as of September 30, 2025.

BlackRock, Inc. has disclosed a 13.3% beneficial ownership stake in Resideo Technologies, Inc., holding 19,722,433 common shares.

BlackRock, Inc. has reported a 5.4% beneficial ownership stake in REZOLUTE INC's common stock, held for passive investment purposes.

BlackRock, Inc. filed an amended Schedule 13G, reporting a 4.9% beneficial ownership in Samsara Inc. common stock as of September 30, 2025.

BlackRock, Inc. has reported a 7.4% beneficial ownership stake in United Parks & Resorts Inc. as of September 30, 2025.

BlackRock, Inc. has reported a 5.4% beneficial ownership stake in SELLAS LIFE SCIENCES GROUP INC, holding 5,686,886 common shares.

BlackRock, Inc. has reported an increased beneficial ownership of 13.4% in Southside Bancshares Inc., holding over 4 million common shares.

BlackRock, Inc. has reported an increased beneficial ownership of 6.8% in Stoke Therapeutics, Inc. common stock as of September 30, 2025.

BlackRock, Inc. has increased its beneficial ownership in Sunrun Inc. to 15.1% of common stock, holding over 34.8 million shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.6% of TETRA TECHNOLOGIES INC's common stock, totaling 10,171,712 shares.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.6% beneficial ownership stake in Trade Desk, Inc.'s Class A Stock.

BlackRock, Inc. reported an amended beneficial ownership of 6.5% in Titan Machinery Inc. common stock, totaling 1,524,675 shares.

BlackRock, Inc. has reported a 5.5% beneficial ownership stake in Tourmaline Bio, Inc., holding 1,411,832 shares of common stock as of September 30, 2025.

BlackRock, Inc. reported an 8.4% beneficial ownership in Universal Display Corp's common stock as of September 30, 2025.

BlackRock, Inc. has increased its beneficial ownership in Wendy's Co to 12.1% of common stock, holding over 23 million shares.

BlackRock, Inc. has reported a 5.1% beneficial ownership stake in MODIV INDUSTRIAL INC's Class C Stock as of September 30, 2025.

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, disclosing a 7.7% beneficial ownership stake in Orchid Island Capital, Inc. as of September 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.5% beneficial ownership stake in EyePoint Pharmaceuticals, Inc. common stock as of September 30, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 14.3% in Frontdoor Inc.'s common stock, totaling 10,408,652 shares.

BlackRock, Inc. has reported a 5.7% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Stock as of September 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership stake in Hallador Energy Co. common stock.

BlackRock, Inc. filed an Amendment No. 18 to its Schedule 13G, disclosing a 9.1% beneficial ownership in Host Hotels and Resorts Inc., representing 62,535,475 shares as of September 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in Incyte Corporation as of September 30, 2025.